ArticleArchives of microbiology2025
Screening and characterization of a high-astaxanthin-producing Xanthophyllomyces dendrorhous strain TP-4 via an efficient evolutionary-enrichment system.
Article in Archives of microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Xanthophyllomyces dendrorhous (anamorph form Phaffia rhodozyma) is a key microbial host for industrial astaxanthin production, where yield depends on both the efficiency of the biosynthetic pathway and overall metabolic robustness. To develop superior industrial strains, we established an efficient evolutionary-enrichment system and an accelerated evolutionary workflow that couples astaxanthin production with cell growth under optimized oxidative stress conditions. This strategy enabled the enrichment of mutants exhibiting both high astaxanthin production and strong industrial fitness. Using this approach, we employed a high astaxanthin-producing X. dendrorhous strain A06 as the parental strain for evolution. After several rounds of screening over 2,000 colonies, we successfully identified the top-performing mutant, TP-4. TP-4 demonstrated a stable 20% increase in astaxanthin production relative to the parental strain, along with faster growth and enhanced fermentation performance. The genome of TP-4 was sequenced, and comparative genomic analysis against the parent strain A06 and a low-astaxanthin-producing control strain, C01, revealed multiple mutations potentially underlying its superior phenotype. These findings provide new insights into the metabolic and genetic basis of astaxanthin overproduction. This work establishes an efficient evolutionary platform for strain improvement and provides a mechanistic understanding of astaxanthin overproduction in X. dendrorhous, laying the groundwork for further optimization and industrial-scale application.
Indexed as
Identifiers
41191067What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.